Kimby E - Search Results

1

Prognostic implications of the microenvironment for follicular lymphoma under immunomodulation therapy.

Menter T, Tzankov A, Zucca E, Kimby E, Hultdin M, Sundström C, Beiske K, Cogliatti S, Banz Y, Cathomas G, Karjalainen-Lindsberg ML, Grobholz R, Mazzucchelli L, Sander B, Hawle H, Hayoz S, Dirnhofer S. Menter T, et al. Among authors: kimby e. Br J Haematol. 2020 May;189(4):707-717. doi: 10.1111/bjh.16414. Epub 2020 Feb 3. Br J Haematol. 2020. PMID: 32012230 Free article.

2

Safety of rituximab therapy during the first trimester of pregnancy: a case history.

Kimby E, Sverrisdottir A, Elinder G. Kimby E, et al. Eur J Haematol. 2004 Apr;72(4):292-5. doi: 10.1111/j.1600-0609.2004.00214.x. Eur J Haematol. 2004. PMID: 15089769

3

Posttransplant lymphoma--a single-center experience of 500 liver transplantations.

Norin S, Kimby E, Ericzon BG, Christensson B, Sander B, Söderdahl G, Hägglund H. Norin S, et al. Among authors: kimby e. Med Oncol. 2004;21(3):273-84. doi: 10.1385/MO:21:3:273. Med Oncol. 2004. PMID: 15456956

4

Mantle cell lymphomas with low levels of cyclin D1 long mRNA transcripts are highly proliferative and can be discriminated by elevated cyclin A2 and cyclin B1.

Sander B, Flygare J, Porwit-Macdonald A, Smith CI, Emanuelsson E, Kimby E, Liden J, Christensson B. Sander B, et al. Among authors: kimby e. Int J Cancer. 2005 Nov 10;117(3):418-30. doi: 10.1002/ijc.21166. Int J Cancer. 2005. PMID: 15900590

5

Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphoma.

Flygare J, Gustafsson K, Kimby E, Christensson B, Sander B. Flygare J, et al. Among authors: kimby e. FEBS Lett. 2005 Dec 19;579(30):6885-9. doi: 10.1016/j.febslet.2005.11.020. FEBS Lett. 2005. PMID: 16337199 Free article.

6

CD8+ T-cell content in diagnostic lymph nodes measured by flow cytometry is a predictor of survival in follicular lymphoma.

Wahlin BE, Sander B, Christensson B, Kimby E. Wahlin BE, et al. Among authors: kimby e. Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):388-97. doi: 10.1158/1078-0432.CCR-06-1734. Clin Cancer Res. 2007. PMID: 17255259

7

Characterization of genetic changes in MCL by interphase FISH on tissue sections.

Sander B, Wallblom A, Ekroth A, Porwit A, Kimby E. Sander B, et al. Among authors: kimby e. Leuk Lymphoma. 2007 Jul;48(7):1344-52. doi: 10.1080/10428190701402903. Leuk Lymphoma. 2007. PMID: 17613764

8

Long-term molecular remissions in patients with indolent lymphoma treated with rituximab as a single agent or in combination with interferon alpha-2a: a randomized phase II study from the Nordic Lymphoma Group.

Kimby E, Jurlander J, Geisler C, Hagberg H, Holte H, Lehtinen T, Ostenstad B, Hansen M, Osterborg A, Lindén O, Sundström C; Nordic Lymphoma Group. Kimby E, et al. Leuk Lymphoma. 2008 Jan;49(1):102-12. doi: 10.1080/10428190701704647. Leuk Lymphoma. 2008. PMID: 18203019 Clinical Trial.

9

Late-onset neutropenia associated with rituximab therapy: evidence for a maturation arrest at the (pro)myelocyte stage of granulopoiesis.

Tesfa D, Gelius T, Sander B, Kimby E, Fadeel B, Palmblad J, Hägglund H. Tesfa D, et al. Among authors: kimby e. Med Oncol. 2008;25(4):374-9. doi: 10.1007/s12032-008-9049-z. Epub 2008 Feb 16. Med Oncol. 2008. PMID: 18278570

10

Expression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: growth inhibition by receptor activation.

Gustafsson K, Wang X, Severa D, Eriksson M, Kimby E, Merup M, Christensson B, Flygare J, Sander B. Gustafsson K, et al. Among authors: kimby e. Int J Cancer. 2008 Sep 1;123(5):1025-33. doi: 10.1002/ijc.23584. Int J Cancer. 2008. PMID: 18546271

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210 results

Search Page

Filters